Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents.
Garcia-Manero G, Matsuno RK, McBride A, Mohammed H, Idryo D, Broome R, Herriman A, Johnson T, Wilkinson K, Schrag A, Johanson C, Izano M, Makinde A, Mukherjee S.
Garcia-Manero G, et al. Among authors: johanson c.
Clin Lymphoma Myeloma Leuk. 2024 Sep;24(9):e283-e292. doi: 10.1016/j.clml.2024.05.007. Epub 2024 May 7.
Clin Lymphoma Myeloma Leuk. 2024.
PMID: 38871557
Free article.